Duncan-Williams is out with its report on Exactech EXAC, reiterating Buy.
In a note to clients, Duncan-Williams writes, "We are maintaining our 2011 revenue and EPS estimates of $207 million and $1.15, respectively. This represents 9% revenue growth and 34% EPS growth compared to 2010. We are reiterating our BUY rating on EXAC and are maintaining our twelve month price target of $23.00. Our price target is 20 times our 2011 EPS estimate of $1.15."
Shares of EXAC closed Monday at $17.35.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in